Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 31, 2006. The report details an application made to The UK Listing Authority and the London Stock Exchange for block listings of Ordinary shares to be admitted to the Official List upon issuance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and share issuance rather than financial performance.
Material Changes
The primary material change reported is the application for block listings totaling 22,140,034 Ordinary shares of 25p each. These shares are designated to rank equally with existing issued shares.
Outlook and Share Issuance Details
The block listings consist of the following allocations under various share option plans:
- 1,000,000 shares under the GlaxoSmithKline Share Option Plan - Ordinary shares.
- 20,000,000 shares under the GlaxoSmithKline Share Option Plan - ADS.
- 1,000,000 shares under the Glaxo Wellcome 1999 Share Option Plan.
- 140,034 shares under the SmithKline Beecham 1989 Executive Share Option Plan - Approved-Ordinary shares.
The filing contains no management commentary regarding future financial guidance, risks, contingencies, or unusual items.
Investor Verification Points
- Confirm the successful admission of the 22,140,034 shares to the Official List of the London Stock Exchange.
- Verify the specific terms and vesting schedules associated with the four distinct share option plans mentioned.
- Review subsequent filings for the actual issuance date and any dilution impact on existing shareholders.